Go Pro

Crescent Capital BDC (CCAP) Competitors

Crescent Capital BDC logo
$9.92 -0.01 (-0.10%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$9.70 -0.22 (-2.21%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CCAP vs. ARCC, CGBD, MFIC, SLRC, and BCSF

Should you buy Crescent Capital BDC stock or one of its competitors? Crescent Capital BDC's main competitors and comparable companies include Ares Capital (ARCC), Carlyle Secured Lending (CGBD), MidCap Financial Investment (MFIC), SLR Investment (SLRC), and Bain Capital Specialty Finance (BCSF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Crescent Capital BDC compare to Ares Capital?

Ares Capital (NASDAQ:ARCC) and Crescent Capital BDC (NASDAQ:CCAP) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Ares Capital has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

27.4% of Ares Capital shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 0.5% of Ares Capital shares are held by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Ares Capital pays an annual dividend of $1.92 per share and has a dividend yield of 9.7%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 13.7%. Ares Capital pays out 142.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Ares Capital has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Ares Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ares Capital$1.17B12.07$1.30B$1.3514.62
Crescent Capital BDC$7.13M51.26$34.51M-$0.09N/A

In the previous week, Ares Capital had 2 more articles in the media than Crescent Capital BDC. MarketBeat recorded 21 mentions for Ares Capital and 19 mentions for Crescent Capital BDC. Ares Capital's average media sentiment score of 0.83 beat Crescent Capital BDC's score of 0.58 indicating that Ares Capital is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ares Capital
12 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Crescent Capital BDC
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ares Capital presently has a consensus target price of $20.60, indicating a potential upside of 4.36%. Crescent Capital BDC has a consensus target price of $12.63, indicating a potential upside of 27.27%. Given Crescent Capital BDC's higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than Ares Capital.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ares Capital
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Crescent Capital BDC
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14

Ares Capital has a net margin of 30.91% compared to Crescent Capital BDC's net margin of -2.02%. Ares Capital's return on equity of 9.80% beat Crescent Capital BDC's return on equity.

Company Net Margins Return on Equity Return on Assets
Ares Capital30.91% 9.80% 4.50%
Crescent Capital BDC -2.02%9.02%3.82%

Summary

Ares Capital beats Crescent Capital BDC on 12 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Crescent Capital BDC (NASDAQ:CCAP) and Carlyle Secured Lending (NASDAQ:CGBD) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Carlyle Secured Lending has a net margin of 14.26% compared to Crescent Capital BDC's net margin of -2.02%. Crescent Capital BDC's return on equity of 9.02% beat Carlyle Secured Lending's return on equity.

Company Net Margins Return on Equity Return on Assets
Crescent Capital BDC-2.02% 9.02% 3.82%
Carlyle Secured Lending 14.26%8.85%3.90%

Crescent Capital BDC presently has a consensus target price of $12.63, indicating a potential upside of 27.27%. Carlyle Secured Lending has a consensus target price of $12.50, indicating a potential upside of 9.94%. Given Crescent Capital BDC's higher probable upside, equities research analysts plainly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crescent Capital BDC
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14
Carlyle Secured Lending
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 24.5% of Carlyle Secured Lending shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by insiders. Comparatively, 0.4% of Carlyle Secured Lending shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Carlyle Secured Lending has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Carlyle Secured Lending, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent Capital BDC$7.13M51.26$34.51M-$0.09N/A
Carlyle Secured Lending$255.57M3.06$69.97M$0.5122.29

In the previous week, Crescent Capital BDC had 17 more articles in the media than Carlyle Secured Lending. MarketBeat recorded 19 mentions for Crescent Capital BDC and 2 mentions for Carlyle Secured Lending. Carlyle Secured Lending's average media sentiment score of 1.88 beat Crescent Capital BDC's score of 0.58 indicating that Carlyle Secured Lending is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Crescent Capital BDC
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Carlyle Secured Lending
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 13.7%. Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 12.3%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Carlyle Secured Lending pays out 274.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Crescent Capital BDC has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Carlyle Secured Lending has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

Summary

Carlyle Secured Lending beats Crescent Capital BDC on 10 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to MidCap Financial Investment?

Crescent Capital BDC (NASDAQ:CCAP) and MidCap Financial Investment (NASDAQ:MFIC) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.5% of MidCap Financial Investment shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by insiders. Comparatively, 0.9% of MidCap Financial Investment shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Crescent Capital BDC presently has a consensus target price of $12.63, suggesting a potential upside of 27.27%. MidCap Financial Investment has a consensus target price of $11.11, suggesting a potential upside of 22.87%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, equities research analysts plainly believe Crescent Capital BDC is more favorable than MidCap Financial Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crescent Capital BDC
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14
MidCap Financial Investment
1 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.11

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent Capital BDC$7.13M51.26$34.51M-$0.09N/A
MidCap Financial Investment$320.88M2.32$63.17M-$0.36N/A

In the previous week, Crescent Capital BDC had 16 more articles in the media than MidCap Financial Investment. MarketBeat recorded 19 mentions for Crescent Capital BDC and 3 mentions for MidCap Financial Investment. MidCap Financial Investment's average media sentiment score of 0.84 beat Crescent Capital BDC's score of 0.58 indicating that MidCap Financial Investment is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Crescent Capital BDC
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MidCap Financial Investment
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Crescent Capital BDC has a net margin of -2.02% compared to MidCap Financial Investment's net margin of -9.85%. MidCap Financial Investment's return on equity of 11.17% beat Crescent Capital BDC's return on equity.

Company Net Margins Return on Equity Return on Assets
Crescent Capital BDC-2.02% 9.02% 3.82%
MidCap Financial Investment -9.85%11.17%4.41%

Crescent Capital BDC has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, MidCap Financial Investment has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 13.7%. MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 13.7%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. MidCap Financial Investment pays out -344.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Crescent Capital BDC has raised its dividend for 1 consecutive years.

Summary

Crescent Capital BDC beats MidCap Financial Investment on 10 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to SLR Investment?

SLR Investment (NASDAQ:SLRC) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

SLR Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than SLR Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SLR Investment$218.54M3.02$92.54M$1.358.95
Crescent Capital BDC$7.13M51.26$34.51M-$0.09N/A

SLR Investment pays an annual dividend of $1.24 per share and has a dividend yield of 10.3%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 13.7%. SLR Investment pays out 91.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Crescent Capital BDC had 11 more articles in the media than SLR Investment. MarketBeat recorded 19 mentions for Crescent Capital BDC and 8 mentions for SLR Investment. SLR Investment's average media sentiment score of 1.08 beat Crescent Capital BDC's score of 0.58 indicating that SLR Investment is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SLR Investment
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Crescent Capital BDC
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

35.3% of SLR Investment shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 8.8% of SLR Investment shares are held by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

SLR Investment has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

SLR Investment has a net margin of 35.20% compared to Crescent Capital BDC's net margin of -2.02%. Crescent Capital BDC's return on equity of 9.02% beat SLR Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
SLR Investment35.20% 7.96% 3.09%
Crescent Capital BDC -2.02%9.02%3.82%

SLR Investment currently has a consensus target price of $14.10, suggesting a potential upside of 16.72%. Crescent Capital BDC has a consensus target price of $12.63, suggesting a potential upside of 27.27%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than SLR Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SLR Investment
2 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
Crescent Capital BDC
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14

Summary

Crescent Capital BDC beats SLR Investment on 10 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Crescent Capital BDC (NASDAQ:CCAP) and Bain Capital Specialty Finance (NYSE:BCSF) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Crescent Capital BDC currently has a consensus price target of $12.63, indicating a potential upside of 27.27%. Bain Capital Specialty Finance has a consensus price target of $12.75, indicating a potential upside of 10.93%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crescent Capital BDC
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14
Bain Capital Specialty Finance
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Bain Capital Specialty Finance has a net margin of 24.22% compared to Crescent Capital BDC's net margin of -2.02%. Bain Capital Specialty Finance's return on equity of 10.40% beat Crescent Capital BDC's return on equity.

Company Net Margins Return on Equity Return on Assets
Crescent Capital BDC-2.02% 9.02% 3.82%
Bain Capital Specialty Finance 24.22%10.40%4.33%

Bain Capital Specialty Finance has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent Capital BDC$7.13M51.26$34.51M-$0.09N/A
Bain Capital Specialty Finance$273.24M2.73$98.76M$0.9911.61

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 13.7%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 14.6%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years and Bain Capital Specialty Finance has raised its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Crescent Capital BDC had 18 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 19 mentions for Crescent Capital BDC and 1 mentions for Bain Capital Specialty Finance. Crescent Capital BDC's average media sentiment score of 0.58 beat Bain Capital Specialty Finance's score of -1.05 indicating that Crescent Capital BDC is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Crescent Capital BDC
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bain Capital Specialty Finance
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Negative

Crescent Capital BDC has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

49.5% of Crescent Capital BDC shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by company insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Bain Capital Specialty Finance beats Crescent Capital BDC on 10 of the 19 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCAP vs. The Competition

MetricCrescent Capital BDCCapital Markets IndustryFinance SectorNASDAQ Exchange
Market Cap$365.88M$5.50B$14.01B$12.71B
Dividend Yield13.29%7.47%5.94%11.16%
P/E Ratio-110.2230.5425.6725.27
Price / Sales51.261,230.81509.9288.20
Price / Cash5.7947.8940.1651.44
Price / Book0.523.532.756.20
Net Income$34.51M$418.04M$1.32B$358.27M
7 Day Performance-4.34%-1.39%-1.17%-2.36%
1 Month Performance-10.47%-1.45%0.26%-2.77%
1 Year Performance-37.25%4.82%9.27%7.64%

Crescent Capital BDC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCAP
Crescent Capital BDC
4.6338 of 5 stars
$9.92
-0.1%
$12.63
+27.3%
-37.3%$365.88M$7.13MN/AN/A
ARCC
Ares Capital
2.5671 of 5 stars
$19.70
-1.7%
$20.60
+4.6%
-11.9%$14.14B$3.05B14.592,550
CGBD
Carlyle Secured Lending
3.3232 of 5 stars
$11.49
-1.7%
$12.50
+8.8%
-17.2%$790.57M$48.71M22.53N/A
MFIC
MidCap Financial Investment
2.9174 of 5 stars
$9.24
-4.0%
$11.11
+20.2%
-28.1%$761.10M$320.88MN/AN/A
SLRC
SLR Investment
4.4495 of 5 stars
$12.46
-0.9%
$14.10
+13.2%
-27.8%$679.82M$218.54M9.23N/A

Related Companies and Tools


This page (NASDAQ:CCAP) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners